
Innovative Pyridinylidene Hydrazones Target Alzheimer’s Disease

It was surprisingly found that the pyridinylidene hydrazone derivatives inhibit AChE and BuChE as well as Aβ fibril formation significantly. They can destroy already formed fibrils. And they are able to cross the blood-brain barrier which is thought to be due to their pKa values and lipophilicity.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup